Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-19T23:52:38.034Z Has data issue: false hasContentIssue false
  • English
  • Français

Assessing a New Phenothiazine

Published online by Cambridge University Press:  08 February 2018

A. A. Baker  and
J. G. Thorpe
A. A. Baker
Affiliation:
Banstead Hospital, Sutton, Surrey
J. G. Thorpe
Affiliation:
Banstead Hospital, Sutton, Surrey
Get access Rights & Permissions [Opens in a new window]

Extract

7044 is a new phenothiazine derivative which can be regarded, pharmacologically, as resembling chlorpromazine much more closely than it does promethazine. It is said to have the characteristic central properties of chlorptomazine more highly developed, and in addition anti-adrenaline properties with anti-histamine properties comparable to those of promethazine. On a theoretical basis it might have the clinical indications of chlorpromazine.

Type
Original Articles
Information
Journal of Mental Science , Volume 104 , Issue 436 , July 1958 , pp. 855 - 859
Copyright
Copyright © Royal College of Psychiatrists, 1958 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Baker, A. A., and Thorpe, J. G., “Some Simple Measures of Schizophrenic Deterioration”, J. Ment. Sci., 1956, 102, 838–846.CrossRefGoogle Scholar
2. Iidem , “Placebo Response”, Arch. Neurol. Psychiat., 1957, 78, 57–60.CrossRefGoogle Scholar
3. Thorpe, J. G., and Baker, A. A., “A Research Method to Assess a New Tranquillizing Drug”, J. Ment. Sci., 1956, 102, 790–795.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.